Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07018869 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 341 to 384v7
  2. Study sites: 340 to 341v6
  3. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 340 · Start date changed from estimate of Oct 1, 2025 to Oct 15, 2025v5 Show 2 more changesShow less
    • Study sites: 0 to 340
    • Start date changed from estimate of Oct 1, 2025 to Oct 15, 2025
  4. Start date: Aug 1, 2025 to Oct 1, 2025v4
  5. Primary completion date: Mar 23, 2029 to May 23, 2029 Completion date: Mar 23, 2029 to Jun 6, 2029 · Start date: Oct 21, 2025 to Aug 1, 2025v3 Show 2 more changesShow less
    • Completion date: Mar 23, 2029 to Jun 6, 2029
    • Start date: Oct 21, 2025 to Aug 1, 2025
  6. Interventions: Internet-Based Intervention (Other), Internet-Based Intervention (Other), Interview (Other), Questionnaire Administration (Other) to Control website access (Other), Intervention website access (Other), Interview (Other), Questionnaire Administration (Other) Secondary endpoints revised (6)v2 Show 1 more changeShow less
    • Secondary endpoints revised (6)

    See this version in full on ClinicalTrials.gov ↗

  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This phase III trial evaluates whether a web-based intervention called Current Together after Cancer (CTAC) works to increase the number of patients with surgically removed (resected) colorectal cancer who receive surveillance care that aligns with current guidelines (guideline-concordant). Surveillance care after resection of colorectal cancer is critical to detect potentially curable return of disease (recurrence), yet up to 60% of colorectal cancer survivors fail to receive surveillance. This may be due to a lack of knowledge about the purpose of surveillance care and the risks of cancer recurrence, or a lack of confidence for managing surveillance care. The CTAC intervention is an online education intervention designed to improve patients' knowledge about surveillance and their self-efficacy for managing surveillance, and to promote effective communication with supporters and supporter engagement in patients' surveillance in a way that is aligned with each patient's preferences. By increasing a patient's knowledge, self-efficacy, and satisfaction with their supporter's engagement in their care, the CTAC intervention may increase the number of patients who receive guideline-concordant surveillance care after resection of colorectal cancer.
Trial Details
NCT Number NCT07018869
Lead Sponsor SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Conditions Colorectal Cancer Stage II, Colorectal Cancer Stage III
Enrollment 1,057 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov